Funded Tech Companies

Epicrispr Biotechnologies

Epicrispr Biotechnologies is a biopharmaceutical venture, based in San Francisco. Financial backing was provided by Fidelity Management & Research Company, Duquesne Capital Management and Angelini Ventures.

Company Overview

Contact Information

Company Background Information

Overview

Epicrispr Biotechnologies is building the world's leading therapeutic platform based on the exciting new technology of epigenetic editing. We were founded by genetic medicine pioneer Stanley Qi, Ph.D., whose fundamental work in epigenetic editing includes the invention of CRISPRa (activation) and CRISPRi (interference). We are translating the powerful potential of epigenetic editing into transformative therapies that can expand the promise of genetic medicine and improve the lives of people with serious diseases.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

8/11/2026

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Amber Salzman

        

Company Investors

• Fidelity Management & Research Company
• Duquesne Capital Management
• Angelini Ventures
• Abrdn
• Sanofi Ventures
• Octagon Capital
• Cormorant Asset Management
• Janus Henderson Investors
• Ally Bridge Group (Andrew Lam)
• Solve FSHD (Chip Wilson)

Browse more funded tech companies:

EpicPledge | Epicrop Technologies

Share this article

About Our VC Deals Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary